Renalytix Plc - ADR

NASDAQ:RNLX  
0.51
+0.04 (+8.34%)
7:56:03 PM EDT: $0.50 -0.01 (-2.52%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)42.47M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.75 Million
Adjusted EPS-$0.07
See more estimates
10-Day MA$0.47
50-Day MA$0.62
200-Day MA$0.88
See more pivots

Renalytix Plc - ADR Stock, NASDAQ:RNLX

1460 Broadway, 5-7 Cranwood Street, New York, New York 10036
United Kingdom
Phone: +1.646.397.3970
Number of Employees:

Description

Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY.